Onkologie. 2025:19(3):152-155 | DOI: 10.36290/xon.2025.028

The growing challenge of malignant melanoma: Strategies for improving care

Júlia Bartková1, 2, Soňa Hrižová3, Sandra Harásková2, Dušana Selecká4, Gabriela Bakšová5
1 Klinika popálenín a plastickej chirurgie, Fakultná nemocnica Brno
2 Lekárska fakulta Masarykovej univerzity, Brno
3 Lekárska fakulta Univerzita Komenského, Bratislave, Slovenská republika
4 Kožní oddělení, Nemocnice Šumperk, Šumperk
5 Stacionár dermatologický, Nemocnia Poprad, a. s., Slovenská republika

Malignant melanoma is one of the most severe forms of skin cancer, characterized by a high risk of metastasis and significant mortality. Although it accounts for only a small proportion of skin tumors, it is responsible for the majority of skin cancer-related deaths. This article focuses on the diagnosis and treatment of melanoma, covering the role of healthcare professionals from primary care physicians to dermatovenero­logists and plastic surgeons, while emphasizing the importance of early detection and a comprehensive approach to patient care. The article also highlights the significance of prevention through UV protection and raising awareness of melanoma risk factors.

Keywords: malignant melanoma, diagnosis, dermatoscopy.

Accepted: June 26, 2025; Published: July 4, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartková J, Hrižová S, Harásková S, Selecká D, Bakšová G. The growing challenge of malignant melanoma: Strategies for improving care. Onkologie. 2025;19(3):152-155. doi: 10.36290/xon.2025.028.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 4.7.2026

    References

    1. Shalata W, Attal ZG, Solomon A, et al. Melanoma Management: Exploring Staging, Prognosis, and Treatment Innovations. Int J Mol Sci. 2024;25(11):5794. doi: 10.3390/ijms25115794. Go to original source... Go to PubMed...
    2. Karimkhani C, Green AC, Nijsten T, et al. Globálna záťaž melanómom: výsledky štúdie Global Burden of Disease 2015. British Journal of Dermatolog. 1. júla 2017:117(1):134-140. https://doi.org/10.1111/bjd.15510. Go to original source... Go to PubMed...
    3. Trindade FM, de Freitas MLP, Bittencourt FV. Dermoscopic evaluation of superficial spreading melanoma. Anais Brasileiros de Dermatologia. 2021;96(2):139-147. doi: 10.1016/j.abd.2020.06.012. Go to original source... Go to PubMed...
    4. Puckett Y, Wilson AM, Farci F, et al. Melanoma Pathology. In: StatPearls. StatPearls Publishing; 2024. Accessed November 26, 2024. http://www.ncbi.nlm.nih.gov/books/NBK459367/.
    5. Tas F, Erturk K. Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival. The American Journal of Dermatopathology. 2022;44(11):799. doi: 10.1097/DAD.0000000000002264. Go to original source... Go to PubMed...
    6. Mihulecea CR, Iancu GM, Leventer M, et al. The Many Roles of Dermoscopy in Melanoma Detection. Life. 2023;13(2):477. doi: 10.3390/life13020477. Go to original source... Go to PubMed...
    7. Loono. Prevence rakoviny kůže. Available from: https://www.loono.cz/prevence/kuze. [cited 11.2.2025].
    8. Stan proti melanomu. Stan proti melanomu - bezplatné vyšetření kůže. Available from: https://stan.denmelanomu.cz.
    9. Garbe C, Amaral T, Peris K, et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer. 2022;170:236-255. doi: 10.1016/­j.ejca.2022.03.008. Go to original source... Go to PubMed...
    10. Gachon J, Beaulieu P, Sei JF, et al. First prospective study of the recognition process of melanoma in dermatological practice. Arch Dermatol. 2005;141(4):434-438. doi: 10.1001/archderm.141.4.434. Go to original source... Go to PubMed...
    11. Dinnes J, Deeks JJ, Chuchu N, et al. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database Syst Rev. 2018;12(12):CD011902. doi: 10.1002/14651858.CD011902.pub2. Go to original source... Go to PubMed...
    12. Esteva A, Kuprel B, Novoa RA, et al. Dermatologist-level classification of skin cancer with deep neural networks [published correction appears in Nature. 2017;546(7660):686. doi: 10.1038/nature22985]. Nature. 2017;542(7639):115-118. doi: 10.1038/nature21056. Go to original source... Go to PubMed...
    13. Ústav zdravotnických informací a statistiky ČR. Maligní melanom - doporučený postup pro pacienty. ÚZIS ČR; 2022. Available from: https://kdp.uzis.cz/res/guideline/36-maligni-melanom-pacient.pdf. [cited 11.2.2025].
    14. Aivazian K, Ahmed T, El Sharouni MA, et al. Correction to: Histological regression in melanoma: impact on sentinel lymph node status and survival. Mod Pathol. 2021;34(11):2091. doi: 10.1038/s41379-021-00878-8. Go to original source... Go to PubMed...
    15. Scolyer RA, Rawson RV, Gershenwald JE, et al. Mela­noma pathology reporting and staging. Mod Pathol. 2020; 33(Suppl 1):15-24. doi: 10.1038/s41379-019-0402-x. Go to original source... Go to PubMed...
    16. Azimi F, Scolyer RA, Rumcheva P, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol. 2012;30(21):2678-2683. doi: 10.1200/JCO.2011.37.8539. Go to original source... Go to PubMed...
    17. Malvehy J, Dreno B, Barba E, et al. Smart e-Skin Cancer Care in Europe During and after the Covid-19 Pandemic: a Multi­disciplinary Expert Consensus. Dermatol Pract Concept. 2023;13(3):e2023181. doi: 10.5826/dpc.1303a181. Go to original source... Go to PubMed...
    18. Krensel M, Schäfer I, Augustin M. Cost-of-illness of melanoma in Europe - a systematic review of the published literature. J Eur Acad Dermatol Venereol. 2019;33(3):504-510. doi: 10.1111/jdv.15315. Go to original source... Go to PubMed...
    19. Liu Y, Jain A, Eng C, et al. A deep learning system for differential diagnosis of skin diseases. Nat Med. 2020;26(6):900-908. doi: 10.1038/s41591-020-0842-3. Go to original source... Go to PubMed...
    20. Dixon AJ, Sladden M, Zouboulis CC, et al. Primary Cutaneous Melanoma-Management in 2024. J Clin Med. 2024;13(6):1607. doi: 10.3390/jcm13061607. Go to original source... Go to PubMed...
    21. Sladden MJ, Nieweg OE, Howle J, et al. Updated evidence-based clinical practice guidelines for the diagnosis and management of melanoma: definitive excision margins for primary cutaneous melanoma. Med J Aust. 2018;208(3):137-142. doi: 10.5694/mja17.00278. Go to original source... Go to PubMed...
    22. Garbe C, Amaral T, Peris K, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022. Eur J Cancer. 2022;170:256-284. doi: 10.1016/j.ejca.2022.04.018. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.